Found 18 matching trials
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer PHASE3 This is a randomized, open-label, three-arm, phase 3 study in men with bioc...
Show More Location
The Mayo Clinic - Phoenix
Learn More & Join Trial
Toxicity Comparison Between Hypofractionated Radiotherapy With HDR Brachytherapy Boost Versus Standard Treatment NA The purpose of this study is to compare toxicities between 2 external beam ...
Show More Learn More & Join Trial
Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT PHASE2 The purpose of this research study is to test the efficacy of ADT on prosta...
Show More Location
Miami Cancer Institute at Baptist Health, Inc.
Learn More & Join Trial
Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancer PHASE2 The purpose of this study is to evaluate the efficacy of TAK-385 for achiev...
Show More Location
Multiple Locations
Learn More & Join Trial
Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients PHASE2 Participants responding well in Study FE200486 CS06 (NCT00117949) were give...
Show More Location
Advanced Urology Medical Center
Learn More & Join Trial
3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy PHASE2 In April 2011, the United States Food and Drug Administration (FDA) approve...
Show More Location
Northwestern University, Feinberg School of Medicine
Learn More & Join Trial
Cardiovascular Events in GnRH Agonist vs. Antagonist PHASE2 The purpose of this study is to test if the use of Degarelix for 1 year ass...
Show More Location
Rabin Medical Center - Beilinson Hospital
Learn More & Join Trial
Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486 PHASE2 Population pharmacokinetic and pharmacodynamic data from Study FE200486 CS0...
Show More Location
Advanced Urology Medical Center
Learn More & Join Trial
Intermittent Treatment With Degarelix of Patients Suffering From Prostate Cancer PHASE3 The purpose of this uncontrolled, multi-center, open-label trial was to inv...
Show More Location
Hospital St Jan Brugge
Learn More & Join Trial
Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelix PHASE4 The aim of this phase IV interventional study is to evaluate variation in b...
Show More Location
Clinical Department of Urology, university Hospital Spedali Civili di Brescia
Learn More & Join Trial